How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

RG

NASDAQ:RGEN
Get a brief AI stock analysisSaves ~ 15 minutes of your time

RG

Repligen CorpNASDAQ RGEN Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is RGEN undervalued compared to its fair value?

The fair value of RGEN stock is hidden USD. Relative to the market price of 123.81 USD Repligen Corp is hidden.

Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,025 full-time employees...[More about valuation]

Repligen Corp Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

7.131 $B

Price:

123.81 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.037

RGEN stock is better priced for investment 0% of the companies in Healthсare sector
RGEN stock is better priced for investment 0% of the companies on Nasdaq Exchange

FINANCIALS

Repligen Corp financial for reporting period

Income Statement

0.15 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0035 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0021 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.15 B 100%
0.076 B 50%
0.0021 B 1%

Balance Sheet

2.8 B
2 B


Financial Position Analysis

Assets

2.8 B
Current Assets
1.1 B
Total non-current assets
1.7 B

Total current liabilities
0.18 B
Total non-current liabilities
0.7 B

Cash Flow Statement

0.036 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.045 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Repligen Corp fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

1 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
1 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is RGEN attractive for investment based on fundamental analysis?

RGEN stock rating is hidden. Repligen Corp is a hidden by Eyestock methodology.

Get RGEN Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

2

Gross Margin:

44

CFO / Debt ratio:

hidden

Current ratio:

3.932

Debt / Equity ratio:

0.22

ROE:

1

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

RGEN analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for RGEN to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Repligen Corp competitors

TM

TMO

Thermo Fisher Scientific Inc

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, an...

Discover

DH

DHR

Danaher Corp

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company is headqu...

Discover

LO

LONN.SW

Lonza Group AG

Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. The company is headquartered in Basel, Basel-Stadt. The company went IPO on 2002-0...

Discover

Repligen Corp dividends

RGEN dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About RGEN stock

About the company Repligen Corp

Market cap $B

7.131

Dividend yield

Shares outstanding

55.5626 B

Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The company is headquartered in Waltham, Massachusetts and currently employs 2,025 full-time employees. The firm's bioprocessing business consist of four franchises, filtration; chromatography; process analytics; and proteins. The Filtration products are used in process development and process scale production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all monoclonal antibody (mAb) based drugs on the market.

RGEN profile

  • Ticker

    RGEN

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    29 April 1986

  • Sector

    Healthсare

  • Industry

    Life Sciences Tools & Services

  • Employees

    2025

  • City

    Waltham

  • Address

    Building 1, Suite 100, 41 Seyon Street

  • Cusip

    759916109